• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在一个大型欧洲系统性硬化症患者队列中进行全血转录组的全基因组分析。

Genome-wide whole blood transcriptome profiling in a large European cohort of systemic sclerosis patients.

机构信息

Scleroderma Unit, Referral Center for Systemic Autoimmune Diseases, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico di Milano, Milan, Italy

GENYO, Centre for Genomics and Oncological Research Pfizer, University of Granada, Andalusian Regional Government, PTS GRANADA, Granada, Spain.

出版信息

Ann Rheum Dis. 2020 Sep;79(9):1218-1226. doi: 10.1136/annrheumdis-2020-217116. Epub 2020 Jun 19.

DOI:10.1136/annrheumdis-2020-217116
PMID:32561607
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7456554/
Abstract

OBJECTIVES

The analysis of annotated transcripts from genome-wide expression studies may help to understand the pathogenesis of complex diseases, such as systemic sclerosis (SSc). We performed a whole blood (WB) transcriptome analysis on RNA collected in the context of the European PRECISESADS project, aiming at characterising the pathways that differentiate SSc from controls and that are reproducible in geographically diverse populations.

METHODS

Samples from 162 patients and 252 controls were collected in RNA stabilisers. Cases and controls were divided into a discovery (n=79+163; Southern Europe) and validation cohort (n=83+89; Central-Western Europe). RNA sequencing was performed by an Illumina assay. Functional annotations of Reactome pathways were performed with the Functional Analysis of Individual Microarray Expression (FAIME) algorithm. In parallel, immunophenotyping of 28 circulating cell populations was performed. We tested the presence of differentially expressed genes/pathways and the correlation between absolute cell counts and RNA transcripts/FAIME scores in regression models. Results significant in both populations were considered as replicated.

RESULTS

Overall, 15 224 genes and 1277 functional pathways were available; of these, 99 and 225 were significant in both sets. Among replicated pathways, we found a deregulation in type-I interferon, Toll-like receptor cascade, tumour suppressor p53 protein function, platelet degranulation and activation. RNA transcripts or FAIME scores were jointly correlated with cell subtypes with strong geographical differences; neutrophils were the major determinant of gene expression in SSc-WB samples.

CONCLUSIONS

We discovered a set of differentially expressed genes/pathways validated in two independent sets of patients with SSc, highlighting a number of deregulated processes that have relevance for the pathogenesis of autoimmunity and SSc.

摘要

目的

对全基因组表达研究的注释转录本进行分析,有助于理解系统性硬化症(SSc)等复杂疾病的发病机制。我们在欧洲 PRECISESADS 项目背景下对全血(WB)转录组进行了分析,旨在确定区分 SSc 与对照的途径,这些途径在地理上多样化的人群中具有可重复性。

方法

在 RNA 稳定剂中收集了 162 名患者和 252 名对照者的样本。病例和对照者被分为发现队列(n=79+163;南欧)和验证队列(n=83+89;中欧和西欧)。通过 Illumina 分析进行 RNA 测序。使用功能分析个体微阵列表达(FAIME)算法对 Reactome 途径的功能注释进行分析。同时,对 28 种循环细胞群进行免疫表型分析。我们在回归模型中测试了差异表达基因/途径的存在以及绝对细胞计数与 RNA 转录物/FAIME 评分之间的相关性。在两个群体中均显著的结果被认为是可复制的。

结果

总体而言,有 15224 个基因和 1277 个功能途径可用;其中,99 个和 225 个在两组中均具有显著性。在复制的途径中,我们发现 I 型干扰素、Toll 样受体级联、肿瘤抑制因子 p53 蛋白功能、血小板脱颗粒和激活等途径出现失调。RNA 转录物或 FAIME 评分与具有强烈地理差异的细胞亚型共同相关;中性粒细胞是 SSc-WB 样本基因表达的主要决定因素。

结论

我们发现了一组在两个独立的 SSc 患者队列中得到验证的差异表达基因/途径,突出了许多与自身免疫和 SSc 发病机制相关的失调过程。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6ae0/7456554/92a8ca691811/annrheumdis-2020-217116f03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6ae0/7456554/e7979b7e6b33/annrheumdis-2020-217116f01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6ae0/7456554/b772051c4d8b/annrheumdis-2020-217116f02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6ae0/7456554/92a8ca691811/annrheumdis-2020-217116f03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6ae0/7456554/e7979b7e6b33/annrheumdis-2020-217116f01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6ae0/7456554/b772051c4d8b/annrheumdis-2020-217116f02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6ae0/7456554/92a8ca691811/annrheumdis-2020-217116f03.jpg

相似文献

1
Genome-wide whole blood transcriptome profiling in a large European cohort of systemic sclerosis patients.在一个大型欧洲系统性硬化症患者队列中进行全血转录组的全基因组分析。
Ann Rheum Dis. 2020 Sep;79(9):1218-1226. doi: 10.1136/annrheumdis-2020-217116. Epub 2020 Jun 19.
2
Signatures of differentially regulated interferon gene expression and vasculotrophism in the peripheral blood cells of systemic sclerosis patients.系统性硬化症患者外周血细胞中干扰素基因表达差异调节及血管营养的特征
Rheumatology (Oxford). 2006 Jun;45(6):694-702. doi: 10.1093/rheumatology/kei244. Epub 2006 Jan 17.
3
The Long Non-coding RNA NRIR Drives IFN-Response in Monocytes: Implication for Systemic Sclerosis.长非编码 RNA NRIR 在单核细胞中驱动 IFN 反应:对系统性硬化症的影响。
Front Immunol. 2019 Jan 31;10:100. doi: 10.3389/fimmu.2019.00100. eCollection 2019.
4
Limited cutaneous systemic sclerosis skin demonstrates distinct molecular subsets separated by a cardiovascular development gene expression signature.局限性皮肤型系统性硬化症皮肤表现出由心血管发育基因表达特征分隔的不同分子亚群。
Arthritis Res Ther. 2017 Jul 4;19(1):156. doi: 10.1186/s13075-017-1360-7.
5
Changes in macrophage transcriptome associate with systemic sclerosis and mediate contribution to disease risk.巨噬细胞转录组的变化与系统性硬化症相关,并介导其对疾病风险的贡献。
Ann Rheum Dis. 2018 Apr;77(4):596-601. doi: 10.1136/annrheumdis-2017-212454. Epub 2018 Jan 17.
6
Integrative Transcriptomic Analysis of Peripheral Blood Monocytes in Systemic Sclerosis and Shared Pathogenic Pathways in Autoimmune Diseases.系统性硬化症外周血单核细胞的综合转录组分析及自身免疫性疾病的共同致病途径
Arch Med Res. 2025 Jan;56(1):103072. doi: 10.1016/j.arcmed.2024.103072. Epub 2024 Aug 28.
7
The interferon type I signature is present in systemic sclerosis before overt fibrosis and might contribute to its pathogenesis through high BAFF gene expression and high collagen synthesis.I 型干扰素特征在系统性硬化症出现明显纤维化之前就已存在,可能通过高 BAFF 基因表达和高胶原蛋白合成来促进其发病机制。
Ann Rheum Dis. 2016 Aug;75(8):1567-73. doi: 10.1136/annrheumdis-2015-207392. Epub 2015 Sep 14.
8
Compendium of skin molecular signatures identifies key pathological features associated with fibrosis in systemic sclerosis.皮肤分子特征纲要确定了与系统性硬皮病纤维化相关的关键病理特征。
Ann Rheum Dis. 2019 Jun;78(6):817-825. doi: 10.1136/annrheumdis-2018-214778. Epub 2019 Apr 5.
9
Integrative analysis of lung molecular signatures reveals key drivers of systemic sclerosis-associated interstitial lung disease.肺分子特征的综合分析揭示了系统性硬皮病相关间质性肺病的关键驱动因素。
Ann Rheum Dis. 2022 Jan;81(1):108-116. doi: 10.1136/annrheumdis-2021-220493. Epub 2021 Aug 11.
10
A macrophage marker, Siglec-1, is increased on circulating monocytes in patients with systemic sclerosis and induced by type I interferons and toll-like receptor agonists.一种巨噬细胞标志物Siglec-1,在系统性硬化症患者的循环单核细胞上表达增加,且由I型干扰素和Toll样受体激动剂诱导产生。
Arthritis Rheum. 2007 Mar;56(3):1010-20. doi: 10.1002/art.22382.

引用本文的文献

1
Platelets as drivers of immunothrombosis in rheumatic diseases.血小板作为风湿性疾病中免疫血栓形成的驱动因素。
Nat Rev Rheumatol. 2025 Jul 7. doi: 10.1038/s41584-025-01276-z.
2
Integration of transcriptome and immunophenotyping data highlights differences in the pathogenetic kinetics of B cells across immune-mediated disease.转录组和免疫表型数据的整合凸显了免疫介导疾病中B细胞致病动力学的差异。
RMD Open. 2025 Apr 9;11(2):e005310. doi: 10.1136/rmdopen-2024-005310.
3
Molecular characterisation of lupus low disease activity state (LLDAS) and DORIS remission by whole-blood transcriptome-based pathways in a pan-European systemic lupus erythematosus cohort.

本文引用的文献

1
Towards a Better Classification and Novel Therapies Based on the Genetics of Systemic Sclerosis.基于系统性硬化症遗传学的更好分类和新疗法。
Curr Rheumatol Rep. 2019 Jul 15;21(9):44. doi: 10.1007/s11926-019-0845-6.
2
Evolving insights into the cellular and molecular pathogenesis of fibrosis in systemic sclerosis.系统性硬皮病纤维化的细胞和分子发病机制的研究进展。
Transl Res. 2019 Jul;209:77-89. doi: 10.1016/j.trsl.2019.02.010. Epub 2019 Feb 23.
3
The multiple mechanisms that regulate p53 activity and cell fate.调控 p53 活性和细胞命运的多种机制。
基于全血转录组通路的泛欧红斑狼疮队列中狼疮低疾病活动状态(LLDAS)和 DORIS 缓解的分子特征。
Ann Rheum Dis. 2024 Jun 12;83(7):889-900. doi: 10.1136/ard-2023-224795.
4
Reactome pathway analysis from whole-blood transcriptome reveals unique characteristics of systemic sclerosis patients at the preclinical stage.全血转录组中的 Reactome 通路分析揭示了临床前系统性硬化症患者的独特特征。
Front Immunol. 2023 Nov 3;14:1266391. doi: 10.3389/fimmu.2023.1266391. eCollection 2023.
5
Contribution of Telomere Length to Systemic Sclerosis Onset: A Mendelian Randomization Study.端粒长度对系统性硬化症发病的影响:一项孟德尔随机化研究。
Int J Mol Sci. 2023 Oct 25;24(21):15589. doi: 10.3390/ijms242115589.
6
Distinct genome-wide DNA methylation and gene expression signatures in classical monocytes from African American patients with systemic sclerosis.非裔美国系统性硬化症患者经典单核细胞中独特的全基因组 DNA 甲基化和基因表达特征。
Clin Epigenetics. 2023 Feb 17;15(1):25. doi: 10.1186/s13148-023-01445-5.
7
ImmUniverse Consortium: Multi-omics integrative approach in personalized medicine for immune-mediated inflammatory diseases.免疫宇宙联盟:免疫介导的炎症性疾病个体化医学中的多组学综合方法。
Front Immunol. 2022 Nov 9;13:1002629. doi: 10.3389/fimmu.2022.1002629. eCollection 2022.
8
Three Distinct Transcriptional Profiles of Monocytes Associate with Disease Activity in Scleroderma Patients.三种不同的单核细胞转录谱与硬皮病患者的疾病活动相关。
Arthritis Rheumatol. 2023 Apr;75(4):595-608. doi: 10.1002/art.42380. Epub 2023 Feb 1.
9
Complement component C4 structural variation and quantitative traits contribute to sex-biased vulnerability in systemic sclerosis.补体成分C4的结构变异和数量性状导致系统性硬化症中存在性别差异的易感性。
NPJ Genom Med. 2022 Oct 5;7(1):57. doi: 10.1038/s41525-022-00327-8.
10
ReDisX, a machine learning approach, rationalizes rheumatoid arthritis and coronary artery disease patients uniquely upon identifying subpopulation differentiation markers from their genomic data.ReDisX是一种机器学习方法,通过从类风湿性关节炎和冠状动脉疾病患者的基因组数据中识别亚群分化标志物,对这些患者进行独特的分析。
Front Med (Lausanne). 2022 Aug 22;9:931860. doi: 10.3389/fmed.2022.931860. eCollection 2022.
Nat Rev Mol Cell Biol. 2019 Apr;20(4):199-210. doi: 10.1038/s41580-019-0110-x.
4
The Long Non-coding RNA NRIR Drives IFN-Response in Monocytes: Implication for Systemic Sclerosis.长非编码 RNA NRIR 在单核细胞中驱动 IFN 反应:对系统性硬化症的影响。
Front Immunol. 2019 Jan 31;10:100. doi: 10.3389/fimmu.2019.00100. eCollection 2019.
5
Emerging targets of disease-modifying therapy for systemic sclerosis.系统性硬皮病的新型疾病修饰治疗靶点。
Nat Rev Rheumatol. 2019 Apr;15(4):208-224. doi: 10.1038/s41584-019-0184-z.
6
Multiplexed enrichment and genomic profiling of peripheral blood cells reveal subset-specific immune signatures.外周血细胞的多重富集和基因组分析揭示了亚群特异性免疫特征。
Sci Adv. 2019 Jan 23;5(1):eaau9223. doi: 10.1126/sciadv.aau9223. eCollection 2019 Jan.
7
Type I interferon dysregulation in Systemic Sclerosis.Ⅰ型干扰素失调与系统性硬化症。
Cytokine. 2020 Aug;132:154635. doi: 10.1016/j.cyto.2018.12.018. Epub 2019 Jan 23.
8
Comprehensive and critical evaluation of individualized pathway activity measurement tools on pan-cancer data.基于泛癌数据对个体化通路活性测量工具进行全面且批判性的评估。
Brief Bioinform. 2020 Jan 17;21(1):36-46. doi: 10.1093/bib/bby097.
9
p53 Expression in Lung Fibroblasts Is Linked to Mitigation of Fibrotic Lung Remodeling.p53 在肺成纤维细胞中的表达与减轻肺纤维化重塑有关。
Am J Pathol. 2018 Oct;188(10):2207-2222. doi: 10.1016/j.ajpath.2018.07.005.
10
Urinary and plasma metabolite differences detected by HPLC-ESI-QTOF-MS in systemic sclerosis patients.高效液相色谱-电喷雾-四极杆飞行时间质谱法检测系统性硬化症患者尿液和血浆中的代谢物差异。
J Pharm Biomed Anal. 2019 Jan 5;162:82-90. doi: 10.1016/j.jpba.2018.09.021. Epub 2018 Sep 11.